Nav: Home

Mayo Clinic researchers identify therapy

March 08, 2017

PHOENIX -- Mayo Clinic researchers have found that an experimental drug, LCL161, stimulates the immune system, leading to tumor shrinkage in patients affected by multiple myeloma. The findings are published in Nature Medicine.

Multiple myeloma is a blood cancer that affects plasma cells - white blood cells that normally produce antibodies to fight infection. Rather than produce helpful antibodies, the cancer cells, as they grow, secrete large amounts of a single antibody that accumulate in the body, causing kidney problems and infections.

"The drug, LCL161, was initially developed to promote tumor death," says Marta Chesi, Ph.D., a Mayo Clinic biochemist and lead author of the study of 25 Multiple Myeloma patients. "However, we found that the drug does not kill tumor cells directly. Rather, it makes them more visible to the immune system that recognizes them as foreigner invaders and eliminates them."

Mayo Clinic researchers will conduct a follow-up clinical trial of LCL161 in combination with an inhibitor of immune checkpoints that has been widely used in many cancer treatments to evaluate if LCL161 could represent a potential new treatment option.

"The model for preclinical studies to predict with great accuracy which drugs would work in the clinic was developed a decade ago," says Dr. Chesi. "And it has been instrumental in the prioritization of which experimental therapeutics should be tested in patients with multiple myeloma."

The research highlights the importance of studying the effects of drugs not only on the tumor cells in a culture plate, but also on the interaction of the tumor cells with their own microenvironment. The finding that LCL161 is active against multiple myeloma suggests that similar drugs may have broader clinical activity than previously thought.
-end-
The work of Dr. Chesi and her team reflects Mayo Clinic's focus to bridge basic science discoveries into clinical trials through collaboration, beginning with unmet patient needs.

Study co-authors are:
    * Ilseyar Akhmetzyanova, Albert Einstein College of Medicine
    * Gregory Ahmann, Mayo Clinic
    * Sikander Ailawadhi, M.D., Mayo Clinic
    * Yan Asmann, Ph.D., Mayo Clinic
    * Leif Bergsagel, M.D., Mayo Clinic, David F. and Margaret T. Grohne Professor of Novel Therapeutics for Cancer Research
    * Francis Buadi, M.D., Mayo Clinic
    * Arianna Calcinotto, Ph.D., Mayo Clinic Asher Chanan-Khan, M.D., Mayo Clinic
    * David Dingli, M.D., Ph.D., Mayo Clinic
    * Angela Dispenzieri, M.D., Mayo Clinic, Serene M. and Frances C. Durling Professor
    * Amylou Dueck, Ph.D., Mayo Clinic
    * Rafael Fonseca, M.D., Mayo Clinic, Getz Family Professor of Cancer
    * David Fooksman, Ph.D., Albert Einstein College of Medicine
    * Victoria Garbitt, Mayo Clinic
    * Morie Gertz, M.D., Mayo Clinic, Roland Seidler, Jr., Professor of the Art of Medicine in Honor of Michael D. Brennan, M.D.
    * Niamh Keane, M.B., Ch.B., Mayo Clinic Heidi Kosiorek, Mayo Clinic
    * Shaji Kumar, M.D., Mayo Clinic
    * Martha Lacy, M.D., Mayo Clinic
    * Yi Lin, M.D., Ph.D., Mayo Clinic
    * Kevin Morrison, Mayo Clinic
    * Noweeda Mirza, Ph.D., Mayo Clinic
    * Craig Reeder, M.D., Mayo Clinic
    * Daniel Riggs, Ph.D., Mayo Clinic
    * Meaghen Sharik, Mayo Clinic
    * Keith Stewart, M.D., Ch.B., Mayo Clinic, Vasek and Anna Maria Polak Professor of Cancer Research, Carlson and Nelson Endowed Director, Center for Individualized Medicine


About Mayo Clinic


Mayo Clinic is a nonprofit organization committed to clinical practice, education and research, providing expert, whole-person care to everyone who needs healing. For more information, visit http://www.mayoclinic.org/about-mayo-clinic or http://newsnetwork.mayoclinic.org/.

Mayo Clinic

Related Immune System Articles:

The immune system may explain skepticism towards immigrants
There is a strong correlation between our fear of infection and our skepticism towards immigrants.
New insights on how pathogens escape the immune system
The bacterium Salmonella enterica causes gastroenteritis in humans and is one of the leading causes of food-borne infectious diseases.
Understanding how HIV evades the immune system
Monash University (Australia) and Cardiff University (UK) researchers have come a step further in understanding how the human immunodeficiency virus (HIV) evades the immune system.
Carbs during workouts help immune system recovery
Eating carbohydrates during intense exercise helps to minimise exercise-induced immune disturbances and can aid the body's recovery, QUT research has found.
A new model for activation of the immune system
By studying a large protein (the C1 protein) with X-rays and electron microscopy, researchers from Aarhus University in Denmark have established a new model for how an important part of the innate immune system is activated.
Guards of the human immune system unraveled
Dendritic cells represent an important component of the immune system: they recognize and engulf invaders, which subsequently triggers a pathogen-specific immune response.
How our immune system targets TB
Researchers have seen, for the very first time, how the human immune system recognizes tuberculosis (TB).
How a fungus inhibits the immune system of plants
A newly discovered protein from a fungus is able to suppress the innate immune system of plants.
A new view of the immune system
Pathogen epitopes are fragments of bacterial or viral proteins. Nearly a third of all existing human epitopes consist of two different fragments.
TB tricks the body's immune system to allow it to spread
Tuberculosis tricks the immune system into attacking the body's lung tissue so the bacteria are allowed to spread to other people, new research from the University of Southampton suggests.

Related Immune System Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Climate Crisis
There's no greater threat to humanity than climate change. What can we do to stop the worst consequences? This hour, TED speakers explore how we can save our planet and whether we can do it in time. Guests include climate activist Greta Thunberg, chemical engineer Jennifer Wilcox, research scientist Sean Davis, food innovator Bruce Friedrich, and psychologist Per Espen Stoknes.
Now Playing: Science for the People

#527 Honey I CRISPR'd the Kids
This week we're coming to you from Awesome Con in Washington, D.C. There, host Bethany Brookshire led a panel of three amazing guests to talk about the promise and perils of CRISPR, and what happens now that CRISPR babies have (maybe?) been born. Featuring science writer Tina Saey, molecular biologist Anne Simon, and bioethicist Alan Regenberg. A Nobel Prize winner argues banning CRISPR babies won’t work Geneticists push for a 5-year global ban on gene-edited babies A CRISPR spin-off causes unintended typos in DNA News of the first gene-edited babies ignited a firestorm The researcher who created CRISPR twins defends...